학술논문

Rapid start antiretroviral therapies for improved engagement in HIV care: implementation science evaluation protocol
Document Type
article
Source
BMC Health Services Research. 23(1)
Subject
Public Health
Health Sciences
Pediatric AIDS
Pediatric
HIV/AIDS
Clinical Research
Health Services
Mental Health
Infectious Diseases
Health and social care services research
8.1 Organisation and delivery of services
Infection
Good Health and Well Being
Humans
Implementation Science
HIV Infections
Acquired Immunodeficiency Syndrome
Motivation
HIV
Rapid start antiretroviral therapy
Implementation science
Evaluation
Mixed methods
Learning collaborative
United States
Library and Information Studies
Nursing
Public Health and Health Services
Health Policy & Services
Health services and systems
Public health
Language
Abstract
BackgroundIn 2020, the Health Resources and Services Administration's HIV/AIDS Bureau funded an initiative to promote implementation of rapid antiretroviral therapy initiation in 14 HIV treatment settings across the U.S. The goal of this initiative is to accelerate uptake of this evidence-based strategy and provide an implementation blueprint for other HIV care settings to reduce the time from HIV diagnosis to entry into care, for re-engagement in care for those out of care, initiation of treatment, and viral suppression. As part of the effort, an evaluation and technical assistance provider (ETAP) was funded to study implementation of the model in the 14 implementation sites.MethodThe ETAP has used implementation science methods framed by the Dynamic Capabilities Model integrated with the Conceptual Model of Implementation Research to develop a Hybrid Type II, multi-site mixed-methods evaluation, described in this paper. The results of the evaluation will describe strategies associated with uptake, implementation outcomes, and HIV-related health outcomes for patients.DiscussionThis approach will allow us to understand in detail the processes that sites to implement and integrate rapid initiation of antiretroviral therapy as standard of care as a means of achieving equity in HIV care.